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Introduction 
Rc:cent advances in immunosuppression. operative tech-
niques and patient management have improved short 
,crm one year survival rates after kidney. liver and heart 
tr:msplantation to more than S00C at most experienced 
c:enters. In fact. organ allograft recipients without major 
post-operati\'e complications are being discharged from 
,he hospital within several weeks of the operation. a sce-
nario almost unheard of even as little as a decade ago. 
These de\c!opments have shifted considerable attention 
in research away from short term problems such as acute 
rejection. to the major obstacles to long-term. morbidity-
tree sun'iva!: chronic rejection (CR)' the subject of this 
review. :.md the adverse effects of maintenance immuno-
~uppressionK which is needed to prevent CR. 
The nature and magnitude of the problem 
CR can be broadl\" defined as a largely indolent. but 
t'rogressi\'e form ot" allograft injury cha~acterized primar-
dy by fibrointimai hyperplasia of arteries. or obliterative 
-lrteriopathy (0.-\). interstitial fibrosis and atrophy of 
rarenchymal elements. For the most part. it is irreversible 
~tnd eventually results in allograft failure. Currentl\". CR 
is the most significant medica! obstacle to long tern; mor-
bidity-free allograft sun·ival. The incidence is thou!!ht to 
i=Drog~essiyDely increase with time after transplantatio~K but 
aft(!r a pt!riod of five years it affects about 1001: of liver to 
~eound 60CC of lung allograft recipients (table 1) [1-11 J. 
The term "(hronic" implit!s a temporally prolonged 
~DlFrrpe and in general. CR more indolently compromises 
\lrgan function. in contrast to acute rejection that can 
rrecipitously caust! allograft failure bt!cause of vascular 
;)ccrosis thrombosis and infarction. However. manv cases 
llf CR clearly evo!\'e from severe or inadequately control-
led acute rejection episodes and in patients not compliant 
with chronic maintenance immunosuppression. In such 
patients. persistent immunologic injury leads to a progres-
,in: de dine in organ function over a period of weeks to 
months. Thae is however. a significant number of patients 
\,'hLl dn not fit these profiles. and slowly develop graft 
tailure L)\er a period of years. This more indolent presen-
tation may be attributable to "clinically silt!nt" rejection 
cpi~lFdes that go undetected or to other factors. 
Alloimmunity was the suspected etiology of CR when 
it was first rt:ported over 3-4 decades ago [12. 13]. Indeed. 
from an immunological perspective. CR could be thou!!ht 
as an iatrogenically-induced autoimmune disease that 
shares many features with chronic graft versus host disease 
(CG\1-ID): However. CR appe;rs to more selectiveh' 
damage tht! arterial tree in comparison to autoimmune 
diseases and GVHD. In fact. obliteration of the aitt!rial 
lumen becaust! offibrointimal hyperplasia. or obliterati\'e 
arteriopathy (OAl. is the pathognomonic lesion of CR. 
The premise that CR is immunologically mediated. is 
best supported by the fact that isografts rarely suffer this 
complication and if they do. it is much delayed and less 
severe in comparison to allografts [14-17J. The impor-
tance of immunologic injury is also supported by many 
clinical studies. in which sevt!rt! or persistent acute rejec-
tion [10. 18-26J. inadequate immunosuppression [So 27]. 
donor recipient racial or ethnic differences[2S-32J. sex 
mismatching[24. 33]. \'iral infections [34-41 J and the use 
of immune activating drugs are cited as risk factors [42). 
The effect of :\rlHC matching on long term ailograft 
sun'i\'al is ~llso used as c\'idence of an immunt! etiology [2S. 
29.31.32.-+3-46]. However. the actual impact of imperfect 
matching on Ion!! term allo!!raft survi\"al has been less than 
expected [OUKP1~-+PD-+4u·-R-1gK With complete six antigen 
matches, immunolo!Zical causes of allograft failure are 
minimized [52.53J . . ~y degrt!e of misriiatching usually 
results in a progressive attrition of graft function over time 
[2S.29.3 1.32.-+3-46]. which is in large part. related to CR. 
Liver allografts however. are an exception. They are rela-
tivel\" resi~tant to CR (table 1) [51] and HL-\ matching 
app~ars to playa dualistic role [54.55]: ~1ismatching in· 
creases the incidence of acute rejection. but \lHC match-
ing might contribute to a greatl.!r susceptibility to recurrent 
inflammatory liwr disease [54]. 
Despite a convincing body of data. a !c\'e! of uncertainty 
still exists about 0.-\ pathogenesis. largely because it i~ 
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Table I. Estimates of the incidence of chronic rejection in various solid organ allografts 
Allograft Incidence of OA at 5 Years References 
Heart 25%-60% (I]. [2]. (3] 
Heart·Lung 8% - 20% (OA) [I J. [4] 
50% - 60% (OB) (I]. [5]. (7]. (8] 
Lung 28/45% (single/double lung) [7] 
liver 3·17%; 10% and decreasing [9]. [10] 
P3I'Icreas alone 30.70%'(late graft loss) (II] 
I Pancreas and kidney 20·40%' [II] 
• EStImates based on gr.lft sur..,.wai rates after one fear. wIth the assumption that most late graft f~lilures are due to CR. 
difficult to study in clinical material. Prior to graft failure 
or death when the entire organ can be histopathologically 
examined. invasive diagnostic procedures are often 
needed to make the dia!Znosis of CR. These tests are often 
subjectively interpreted. The issue is further confused by 
athaosclerotic donor disease [56-58]; the development of 
atherosclerosis arter transplantation. and the observation 
in some studies that 0:\ is associated with conventional 
risk factors ror atherosclerosis [59-62]. Lastly. the various 
Of!Zans are .affected differt!ntlv bv CR. so there is no 
gt!neric definition that can equally applied across all or-
gans. For example. in heart allografts. the primary mani-
festation of CR is OA and progressivt:! ischt:!mic damage 
[1.63-65]. In lung allografts. destruction of the small bron-
chioles (obliterative bronchiolitis) is the major insult lim-
iting long-term survival [1.7.22.66-68]. wht:!rt:!as the vascu-
lar disease is generally considt:!red to be of secondarv 
importance [1. 7.22.66.6 7]. In the liver. both bile duct loss 
and OA. (see below) togetht!r contribute to allog:raft fail-
ure [69-73 J. :'-ieverthd;ss. tht:!re are many similarities in 
the various manifestations of CR between solid organ 
allografts [63. -:".+. -:"5]. \vhich enable us to initially cover tht! 
topic from a common pathophysiological perspective. The 
organ-~pecific peculiarities that exist. often arise as a rt!-
suIt of physioanatomic variations. some of which in tum. 
can int1uencc the immunological mechanisms responsible 
tor the injury. 
Common features of chronic rejection 
ll!!rodllction 
In this section. we will rt:!view the common findings of CR 
in various solid orzan alIozrafts. which include: 1) graft 
vascular disease or ~Fbliter:1tive arteriopathy(OA.); 2) lym-
phohistiocytic intcrstiti:.ll intlammation: 3) patchy intersti-
tial fibrosis. 4) destruction and atrophy of parenchymal 
cdls; 5) destruction and atrophy of org:m-associated lym-
phoid tissues and lymphatic vessels. 
Graft vascular disease or obliterative arteriopathy 
(OA) 
DistnbwiolZ or tilt! Lt!siol1s 
The: ch:1ractc:rization of OA:1s a diffuse concentric intimal 
thickenin\! inn)lvinz the entire intra·ur\!an arterial tree 
[ri3.o.+. 7'+_-/0 1 is gen~rally helpful in distinguishing it from 
utherosckro~isK \\ hich is endemic in the general popula-
tion. However. in an indi\idual lesion. it is not always 
possible to distinguish between the [\vo disorders [60.77.78]. 
This is particularly true for organs such as the heart that 
are normally pront! to atht!rosclerosis. but less of a prob-
lem in athero-resistant org:ans. like the liver. In an effort 
to avoid confusion. "oblit~rative arteriopathy" (OA) will 
be used throughout this review to refer to allograft arterial 
disease associated with rejection. where:1s the. term ·'athe· 
rosderosis" (AS) will be used for the common endt:!mic 
dise:1se. realizing that tht:! distinction is less than perfect. 
The distribution of 0:\ ksions in allografts is one of the 
kev features used to distinguish it from .-\S. Whereas AS 
preferentially affects the -large extracorporeal arteries 
[1.63.64.7-+] ; it has been repeatedly shown that 0:\ more 
often involves both the extra-organ (e.g .. epicardial. he:-
patic hilar. etc.) and first. second and third-order medium· 
sized intra-organ muscular arteries [1.63.6.+.7.+-76]. How-
ever. it has been our experience that 0:\ lesions are not 
as diffuse as ant! might expect from a review of the pathol-
ogy literature [1.63.6·U.+-76] . Even though smalkr arter-
ies are involved. the ksions in both lar!!e and smalkr 
arteries are often patchy in distribution. -and it has also 
bt:!en our impression that they often begin and t!volve more 
quickly near br:mch points [63]. 
Small arteries (.+0-50 ,urn in external diamt:!ter) and 
arterioles commonly sampled in liver. heart and intestinal 
allograft biopsies can also be involved with OA: but it i~ 
much less common than large and mt!dium-sized vessd 
diseast:! [63.79] and the changt:!s seen are less spt:!cific for 
tht:! diagnosis of CR [63]. ~kdial hypertrophy and/or mu· 
ral hyalinization and eventually, frank destruction of the 
microvascul:1ture. have been described in renal and liver 
allografts \vith CR [69.80.81]. Misorientation and com· 
partmentalization of medial smooth muscle cells and ad· 
ventitial fibrosis hJve bt:!en described in small subendo-
cardial arteries from cardiac allografts (79). but thest! 
lesions do not nect!ssarily correlate with the presence or 
absence of OA. 
Arterial inflammation 
Becaust:! OA is so strongly correlated with an alloimmune 
rt:!sponse. it is tempting to concludt! that arterial int1am-
mation causes the damage by rt:!cognizing normally t'x-
pressed or upregulated class I and II donor \tHC antigens 
on the endothelium [63.82·86] . Howe\t!r. arterial int1am· 
mation is not always observed [87.88) and fibrointimal 
hyperplasia can progress \vithout it [;-)8-92). When inflam-












Fig, I, a) This section shows a hepatic artery branch in the hilum of a liver allograft, It IS stained with a douole frnmu~olabeling procedure for smooth muscle 
actln(red) and macrophages(CD68: brown), Note the severe lumenal narrowing because of obliterative artenoDathy and destruction of the media along one 
half of ItS clrcumference(A = adventitia: M = media: I = intima), Note also the concentnc ring of myof,brooiastslarrow, that seD3rateS me deep Intimal 
macro phages from the endothelium. whICh IS Intact and uninflammed, Extension of the macrophages from the adventitia thcough to me deep Intima suggests 
that some of the arterial Inflammation may begin in the adventitia and may contribute to the develooment of OA WltnOut Directly involving the Intima, 
b) A higher magnification of the subendothelial ring of myofibroblasts shows them to be mitotICally JCtlve{arrow: doubie staining ior smooth muscle actin 
Ired) and proliferating cells, Ki-67 (brown)}, c) The ring of deep intimal Inflammatory cells IS also ""totlcallv aC:lve<douole stalnl~g for macroohages (CD68: 
red I and proliferating cells, KI-67 (brown)}, d) Double labeling for smooth musde cells I actin: brown I ant: male cells ;Y chromosome Ir sr:u hvtmdlzatlon, 
yellow dotl shows that the Intimal myofibroblasts In the female reCipient of a male liver are of donor ong'n 
mation is not st:en. it is thEFu~ht that antibod\' alone initi-
ates the damage. or that the stereotypic vascular rt:pair 
rt:sponsc can proceed without continued immunolugic 
injury [SLJ,Y2]. 
Even thllugh OA can app,m.:ntly occur withl1ut intlam-
mation, most in\'(.:stigators w()uld conceuc that cellular 
immunity importantly Cllntrihutl.:s tn its uc\,elllpmcnt in 
many cascs, The prckn:ntiallucalization of !t.:ukucyt,;s in 
th,; ,IJventitia and intima SU!!!!,;sts that these ,Ire the m,lst 
important antigenic t<lrgets--ur sites of uam,lge [113,-:-:', 
pO-~RIlFPzI The ad\entitia is rich in lymphatics and d,lIHlr 
dendritic celb making it a site III buth peripheral s,;nsiti-
zation and a conduit for ,;migrating leukocyte~ in acute 
reJection [hPIpOKpRh"IlF~IlF-+jI When r<..'jection is mild, the 
intlammation is usually limited tll the adwntitia [S-:-j, 
\\'h,;n it is unusually s,;\ere.llr when the recipi,;nt harhllr" 
anti-doIlllr antih'ldies. mononuclear and or nelltrurhilic 
endotheliti~I rl.:sl:Jecti\ ely. are usually alsl) present ['7-+, T~I 
S2,95-101], In m:lIl\ cas<..'s tile intimal intlal11l11~ltilln i, 
Ljuickly fullll\\ cd h: tihruil1tind h\rnrla"ia, \\ Ilich mark> 
the hcginnin!! 01 0,-\, 
qhc-intlan~m:ltilln ullL'n per"I\!' in 0:\ Ic,illns IhE1yyin~ 
fibrointimal hYrerpl:l,j;I, ,\l lhi' ItKl~~DI th<.: h mphocyt<..', 
rr,;sent might he rl"Dll~lll/ill~ Ill1l1-\IHC dl1tl~I;nEsFK like 
h,;at Shlll'k prllkin [III'::!, 111 :111: '':\<.:111. It i, liI'l'h tll,lt to\IC 
effeCtllf mllk,'uk, .illc! C\ lllh.ill,;' I\:i.-;I,-.:d :': til,; intlam-
Ill,ltor\' (ell, c'cIlltril,l.I!c' tll cliDrlll~lll1ll ,1\ ,lrt<.:fl:tI \\,tli h(l-
lllellDt~fDg" ,IIlLi :lrt<':l'l.tl I'l'J1ll1lklllH:, '11lL'l' thl' t\\ll 11l"t,;n 
l'(l-e\i,t 1EFK~KpO-y~Iy11fI 11(l\ll''''I', t-hl' 11111.lmnLltllry cell, 
,ltt<..'n hL·Cllfll<.: '<.:i';ILltL'L1 Ir11l11 Ihl' l'llcil1l11,;lt;tI /:Iyer hy ,I 
cllnc,;ntric rill:': c>I illlllllalll1\(ll ti'l'lll,I;I,t' Eli~I 1 I, Thu", th,; 
intbIl1ll1atl(lll-i, 11,1 ICIIl!!l'I: dill',:tl\ ,1"cll'i:IIL'd \\itll the 
<..'ndllthclilll11, 11l'[<.:;ld, n-lllrlll' ,I 11;1!..: III tll~D dl'l'p Intima, 
Illlich i, 'l'11:ILIIL'd 11'11111 ,Illlil 111,llh,'1l111l.tl In;krllphagc' 
1'\ thc Illl',li:1. Till' 11111 11111;111111LI[;11'\ l','il f'l,[,ul;ltilln" arc 
c;)lln<.:ctl'li \\ ith \,.';,,'11 l<lilL'! \ 1:1 ;, ,tl"lill ,11 indilidu:ti 
intlaIl1Illallll'\ (,'II- tiLl! 11l'lllll';11L' hl'l\IL','n \;k'u,,Jat,;d me-
dial 111\'''<..'\tl'', rlli, Dlf~~l·DtD tll;'1 lh 11:1mll' tLtlti<.:king l1C-
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Fig. 2. Schematic of the sequential steps in the development of obliterative arterlopathy. which is the common feature of chronic rejection in all solid organ 
allografts. A normal artery is shown in frame I. illustrating the important anatomic features including the endothelial lining (endo). which is flattened and 
inactive-appearing. the internal elastic lamina (iel). the media (med) and the dendritic cells(dc) located near draining lymphatics In the adventitia of arteries. 
Frame 2 shows early arterial changes during acute rejection and two distinct. but not mutually exclusive pathways of arterial inlury. In severe acute relection(a) 
the endothelium and Intima can be direcdy injured by antibodies/complement and/or inflammatory cells. which leads to an intimal repair response and 
myofibroblast proliferation. However. arterial damage can also occur in less severe relection episodes. illustrated by pathway (b). Inflammatory cells 
accumulate near adventitial donor dendritic cells and draining lymphatics. This causes edema of the media and intima with damage of individual medial 
myocytes. and indirect Inlury of the endothelium. Endothelial hypertrophy and activation occur with both insults and the arterial repair response is triggered. 
Frame 3 illustrates some of the latter changes in the development of OA. A concentJric ring of myofibroblasts develops immediately subjacent to the 
endothelium. which returns to a more quiescent appearance. The media also becomes thinner. presumably as a result of migration of myocytes to the intima 
and/or compensatory arterial dilatation. The macro phages and lymphocytes now accumulate in the deep Intima and focally stJream through the disrupted 
media. This results in a connection between the intimal inflammatory cells and the cuff of macrophages and lymphocytes in the adventitia. The arrangement 
suggests that adventitial to intimal trafficking of immune cells is an important entry route. It occurs at a time when fibrosis is developing in the adventitia 
around affected arteries and in the interstitium. 
curs between the adventitial and the deep intima. while 
the endothelium remains intact. 
Immunophenotypic analyses have shown that the arte-
rial int1ammation consists primarily of an admixture of 
T-Iymphocytes ;}mi macrophages [60.63.82.83.86.103]. In 
some studies. CD8-+- T cells are the most common [83. 
103] . a subset of which show perforin positivity. identify-
ing a cytolytic effector pathway [83.86]. CD4/CD8 double 
negative ;}nd yO T cells have been cultured in vitro from 
affected vessels [104]. The presence of occasional den-
dritic cells. signals ongoing antigenic presentation [82]. 
Nlacrophages however. often become the predominant 
int1ammatory cell population. which may be related to the 
incre;}sed deposition of ground substance and lipid trap-
ping. both of which stimulate phagocytosis(see below) [60. 
63.82.86.103.105-107]. The macrophages permeate the 
;}dventitia. media and intima. and proliferate within thl! 
artery [63]. Foam cell transformation is more common in 
e;}rly lesions ;}nd most often seen in liver allografts [60.63. 
72.i4.75.105-108]. An adventitial-to-intimal macrophage 
sizl! gradient is ;}iso often observed: those nearl!st to thl! 
luml!n h:.m: abunli;}nt foamy cytoplasm. ones in the adven-
titia an.: smaller. Othl!r intlammatorv cells. such as dl!n-
dritic cells [i\2]. B cells [03.82]. eo'sinophils [109] and 
plasma cells ;}re much less commonly observed [63.82]. 
Mural histopathology 
In pr3ctic31 tl!rms. graft vascular diSI!<lst! can he cquatl!d 
with obliterative arteriopathy (OAl. because vein involvl!-
ment is both significantly kss common and less severe [66. 
74.108]. Thl! reason for preferential arterial targeting is 
uncertain. but hemodynamic factors. thl! prototypic arte-
rial responsl! to injury [110-112] • endothelial antigenic 
differences and uniqul! mechanical factors related to lym-
phatic disruption [87] . are possible explanations. 
It sl!ems clear that OA I!volves from a repair responsl! 
to vessd wall injury. and all three layers of thl! artery wall 
are involved: intima, ml!dia and adventitia 
[63.74.111.113]. Documentation of the sequential changes 
have largely relil!d on a reconstruction of events from 
failed human allografts and autopsy specimens, and from 
detaikd sl!quential analyses of experimental animal mod-
ds. Common early findings include endothelial activation. 
which histologically manifests as hypertrophy or a "hob-
nail" appearance \vith eosinophilic transformation of the 
cytoplasm [SPKpRK~nK1141K This impression is supported by 
the appearance of functional I!ndothelial activation [114. 
115] . including uprl!gulation of class II NIHC and adhe-
sion mokcules [63.87.116-120] , and damagl! that can be 
objectivt!ly documented via a Fas-based apoptotic path-
way [So]. In turn. endothelial damage results in loss of 
barrier function ;}nd the int1ux of clotting protl!ins( includ-
ing fibrin). platelets. blood cells and lipids. all of which 
disrupt intimal homeostasis and contributt! to the repair 
response and vascular narrowing(see bdow). Edema ami 
an increased deposition of intercellular matrix and lipid 
[105] . and a local turnover of cells [86.87] an.: seen in all 
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which results in recruitment of medial myocytes and infil-
tration of foamy macrophages [74.77.82.95-100]. This is 
followed by intimal myofibroblast proliferation, that even-
tually replaces the entire intima. Breaks in the internal 
elastic lamina are variably present [63]. 
In the media, early changes include edema. and degen-
eration or frank nec .. osis of individual myocytes [87.93]. 
Later. the media can become thinned [63.81] • presumably 
as a result of intimal migration of medial myocytes in 
response to injury. In fact, the media can be completely 
replaced by foam cells and/or fibroblasts so that the artery 
is no longer a flexible muscular conduit. but a rigid or 
loosely-wall tube formed by fibroblasts or foam cells. re-
spectively. 
Changes in the adventitia of arteries have received far 
less attention than they deserve. Early after transplanta-
tion. the adventitia is a primary site of sensitization, which 
results in inflammation and edema [87.94]. The adventi-
tial inflammation often persists [63.82.87] and is followed 
by adventitial fibrosis [79.87] in the fully developed le-
sion~K Ultimately. disruption of arterial wall homeostasis 
and lumenal narrowing predisposes to thrombosis and 
organ ischemia. Prototypic events are reconstructed in 
fig. 2. 
Lipid and glycosaminoglycan deposition 
OA is not commonly thought of as a lipid-dependent 
disorder. but there is evidence to suggest that hyper-
lipidemia can hasten its development [59.61.62,97] and 
measurement of the lipid content of arteries affected by 
OA show increased mean total cholesterol. esterified cho-
lesterol. free cholesteroL and phospholipid content and 
concentration [121]. However. grummous atheroma. cal-
cification and cholesterol clefts are less frequently ob-
served in OA than in AS. McManus and colleagues [105. 
121] compared the patterns of lipid and glycosaminogly-
can deposition in arteries affected by OA to that seen in 
AS in the general population. The lipoproteins seen in OA 
consist primarily of Apo( a) and apoE. which is in contrast 
to AS. where apoB is more prominent. Also. the apoE 
deposits can be seen in endothelia and in the extracellular 
space of the superficial intima with mild disease early after 
transplantation. and in the deeper intima with severe OA 
[107]. Co-localization of glycosaminoglycans shows that 
biglycan is particularly prominent in the intima of evolving 
OA lesions. but not in AS. Decorin is present mainly in 
adventitia of all vessels and in the intima of AS. Prominent 
versican accumulation is seen in the intima and media of 
arteries with OA. associated with smooth muscle and foam 
cells and the intimal biglycan and versican deposits posi-
tivelv correlate with the extent of luminal narrowin!! in OA 
[106·J. Interestingly. the areas of Apo( a) and apoE depo-
sition are also the sites of prominent proteoglycan sedi-
ments. especially versican. McManus. et al hypothesize 
that arterial injury. either mechanical and/or immuno-
logic. leads to dramatic increases in intimal lipoprotein 
permeability and increased lipid retention within the ar-
terial wall. This presumably occurs because the lipid inter-
acts with chondroitin sulfate proteoglycans. including ver-
sican. which in turn. results in accelerated lipid endocy-
tosis by macrophages and smooth muscle cells [107]. and 
foam cdl transformation. 
Intersrilial injlammation 
Chronically rejecting liver. heart. intestinal and pancreatic 
allografts often show very mild and patchy intlammation. 
whereas in renal allografts. it can be more pronounced 
because of withdrawal of immunosuppression prior to 
allograft nephrectomy. The inflammation consists mostly 
of lymphocytes. macrophages and plasma cells. Forma-
tion of nodular lymphoid aggregates. some of \vhich also 
contain germinal centers, suggests ongoing antigen pres-
entation and continual stimulation [87.122]. The aggre-
gates are often located in the adventitia of arteries. and 
near the serosa or capsule of organs [87.122.123]. which 
are also the site of draining lymphatics. Inflammatory cells 
are also individually scattered throughout the intersti-
tium. where they are seen in dose association with pa-
renchymal cells undergoing damage and atrophy. 
Immunophenotypic studies have shown primarily 
CD4+ and CD8+ T cells. occasional eosinophils [109] 
and macrophages [87.122.124-127], the latter which can 
be quite prominent. Compared to acute rejection. there 
are usually more B cells [I 16.127.128]. and formation of B 
cell follicles is not uncommon. Increased transcripts for 
granzyme B: the presence of Th1-like cytokines IL-2 and 
IFN-y [126] and the prominence of macro phages. suggests 
that CR is mediated by an immune response tilted toward 
the nn pathway. 
Damage and atrophy ofparenclnmal cells alld i11lersririal 
fibrosis 
Epithelial cells which rest on a conventional basement 
membrane. particularly those that line conduits used for 
exchange of substances with the environment (e.g .. bron-
chioles. bile ducts. pancreatic ducts. renal tubular epithe-
lium). are particularly prone to damage during CR. There 
are at least several possible explanations for this observa-
tion. which are covered in greater detail in a recent review 
of the immunopathology of liver allograft rejection [129]. 
Basement membranes contain matrLx components impor-
tant to the migration. positioning and co-stimulation of 
T-cells [129J. In addition. epithelial cell "immunogenicity" 
is enhanced by unique antigenic profiles [129J and their 
ability to upregulate immunologically active adhesion and 
co-stimulatory molecules and to produce cytokines and 
growth factors [129.130). Since the epithelial-lined con-
duits also transport antigens to and from the environment. 
they are often intermLxed with antigen presenting cells. 
and surrounded by a rich lymphatic plexus (see below). 
which drains to the regional lymph nodes. This is normally 
a site of local immune activation to environmental and 
microbial antigens. which in an allograft. could trigger 
rejection. iast~DK the bile ducts and bro-nchioles are al~ost 
exclusively supplied by an arterial circulation. obliteration 
of which can cause ischemic injury. Thus, both direct 
immunologic injury and ischemia likely contribute to the 
damage and loss of small bile ducts and bronchioles during 
CR [69.131]. 
Patch\' interstitial fibrosis is another hallmark feature 
of CR. but alone. it cannot be used as a reliable predictor 
of CR in peripheral biopsy sampJcs[ 132]. Small scars are 
frequently seen as a result of previous hiopsies or other 
insults. Nevertheless. fibrosis is a wnstant feature of CR. 
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the connective tissue normally surrounding the arteries 
affected bv OA. This is combined with more localized 
intc:rstitial" widening [631. especially in areas of ongoing 
immunologic damage. which are often associated with the 
deposition-of tenas;in and other matrix components [133. 
l3ol]. endothelin [1351 and activation of interstitial myofi-
broblasts [1P~zK Luger scars representing healed infarc[s 
and fibrosis in watershed regions supplied by the terminal 
circulation. suggest that ischemic injury also contributes 
to tibrogenesis-[63]. 
Dismption of (\'mphatics and organ associated ~vmphoid 
tissues 
Complete revascularization of an allograft results in the 
circulation of recipient immune cells through donor or-
gan-associated lymphoid tissues( GALT. BAL T. portal 
lymphoid tissue) [1PS-1~lz and regional donor lymph 
nodes E1~1zK Early after transplantation. this results in a 
"in vivo mixed lymphocyte response". which typically 
manifests as acute rejection [136-139.141]. Transplanta-
tion also disrupts the et'ferent lymphatics. which results in 
organ edema and contributes to the re-implantation re-
sponse. The lymphatic channels reconnect within two to 
three weeks [1 .. r:. 143] in the absence of additional insults. 
.-\cute rejection however. results in the increased produc-
tion of lymph t1uid and at the same time. disrupts the 
lymphatic microvasculature. both of which contribute to 
the reappearance of graft edema and swelling during 
rejection reactions [1~OK1~-14izK In CR. the organ-asso-
ciated lymphoid tissue. such as the BALT [14i.148] or 
GAL T [139J. is destroyed and replaced by fibrosis. Patchy 
interstitial fibrosis also focally disrupts intra-organ lym-
phatics lSi. 1~9zK Borh of these changes undoubtedly con-
tribute to an inability of chronically rejecting allografts to 
adequately process infectious agents and antigens that are 
normally cleared via these pathways [13.3;.40.148.150-
152]. In :1duition. disruptIon of lymphatic drainage alone 
h;.ls been shown to produce ;.lrterial injury. \vhich resem-
hb changes ,een with developing OA [153 J. Thus. we [87J 
anu others before us [149]. have suggested that this poten-
tial mech;.lnism of ;.lrterial injury might importantly con-
tribute to the development at OA 
The direct injury model of pathogenesis 
Camels) of the anerial injury 
.-\Dimal models are an excellent way of controlling experi-
mental conditions to isolate the various arterial insults. 
\Iany models that study immunological injury ameliorate 
:1cutc rejection. so the allograft survives long enough to 
ucvelop CR and OA One approach exploits a weak im-
munologic:ll barrier. where only mill or histocompatibility 
barriers :lrC crossed( e.g. LEW to c-P4~ rats) [9R-99K1R~K 
155]. Another approach uses transient treatment with 
various forms of immunosuppression with the most popu-
br being :1 short course of :1nti-Ca~ monoclonal antibod-
ies [S5.115]. The percent:1ge of animals surviving long 
term and de';eloping 0.-\ em be adjusted bv titrating or 
;.ldding immunosuppression. uepending on the model~ 
In these models. there is relentless direct immunoloai-
. . ~ 
C;.ll InJurv to thc allogeneic arteri;.ll enuothelium from 
prolonge·d. non-Iethal';cute rejection. that appears to be 
mediateu primarily by T lymphocytes. m;.lcrophagcs and 
anti-donor antibodies [85.95.98.99.114.115.154,156]. This 
quickly evolves into CR and OA. much like the clinical 
cases that directly evolve from an inadequately controlled 
acute rejection. Indeed. on the basis of these models and 
clinical studies [63. 75. n. lSi], many investigators would 
support the following pathogenesis of art: direct lymphohisti-
ocytic inflammation of allogeneic endothelium or alloantibody 
binding .... endothelial cell damage .... release of cytokines and 
growth factors by endothelial cells, myofibroblasts and inflam-
matory cells .... disruption of intimal homeostasis .... intimal 
myofibroblast proliferation .... lumenal narrowing. For the 
purposes of discussion. this will be called the "DIRECT 
INJVRY HYPOTHESIS". 
Substitution of immune deficient and/or knockout 
mice as recipients into these schemes. has further clarified 
the nature of the immunological injury by isolating the 
contribution of humoral and cellular components [88.91]. 
The development of OA in combined immune deficient 
mice treated with repeated injections of exogenous anti-
donor antibodies [88] nicely illustrates the importance of 
antibodies. Other models also clearly show a role for 
:mtibody-mediated damage [158.159]. ·However. OA also 
develops in B cell knockout mice that presumably are 
incapable of an antibody response [88.91 J, showing an 
important contribution by cellular immunity. Other in-
sults that could contribute to the arterial injury or repair 
response include preservation/peri-operative ischemic in-
jury [160.161J; cytomegalovirus infection [34.64]; altered 
mechanical or hemodynamic forces because of either -de-
creased renal nephron mass [6]. or immunologically-me-
diated lymphatic disruption [8i]; and other well-known 
atherogenic insults such as hyperlipidemia. hypertension. 
diabetes and smoking. 
.'vfechanisms of m.vofibroblast proliferation 
Expt:rimental animal models have also nicely shown that 
the initial arterial insult may be immunologic( antigen 
dept:ndent). but the srereorypic repair response that fol-
lows does not appear to require the persistent influenc.: 
ot JlIoimmunity at some stage in its development( antigen 
inuependent) [89. 90. 92]. Thus. regardless of the sourct: 
or mechanism of injury. the response of the vessel wall ;s 
the tinal common pathway for tht: development of disease 
and ultimately. organ dysfunction. This has led to a natural 
pre-occupation with understanding the molecular mecha-
nisms of myofibroblast proliferation [162]. To study this 
response. a number of investigators use the isolated aortic 
::lllograft mouel. introduced by Hayry [19]. Although it 
lacks the organ parenchyma [92. 94. 163-166], this model 
offers a quick way of screening agents that might be of 
potential therapeutic benefit(Hayry. personal communi-
cation). 
Research to date has implicated multiple and redun-
dant signaling molecules that initiate and/or promote 
smooth muscle cell proliferation and fibrogenesis [19.9i. 
162.167 -171]. similar to the situ:ltion obst:!r .... ed with AS in 
th..: genaal population [172-175 J. This includes growth 
factors. cytokines and chemokines [17.19.9i.llS.156.162. 
lfJ;-li1.l76-1S0]. Fl)r exampk. it has been shown th;.lt 
platdet-derived growth factor A and B [16i.168.1S1J. fi-
broblast growth factor [167.170.181]. insulin-like growth 
factor .. l [162J and interkukin-l[162] can bt! rdeased by 
& 
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mvofibroblasts. endothelial and inflammatory cells into 
th~ arterial intima and all of them can stimulate smooth 
muscle cells to migrate to the site of injury and proliferate. 
Macrophages appear to be an important source of mole-
cules causing damage. and initiating the repair response 
and fibrogenesis [17.97.11S.126.l5-t-156.176.177.lS3 J. 
This helps explain the inhibition of OA by an essential 
fatty acid deficient diet. which interferes with leuko0·te 
chemotaxis [97], Transforming growth factor-beta 1 might 
importantly contribute to fibrosis (13-t.167.169.17l.179]. 
Interleukin-6 might has been linked to the glomerular 
proliferative lesions in chronic renal allograft rejection 
[118J. The reader is referred to several excellent reviews 
for a more detailed accounting of this complex area [19. 
21.161.162.167,1 72-174,183.184]. 
Manifestations of chronic rejection in specific organs 
Lil'er allografts I~ .• - J • • ill .' l ~DDD: "&-
Chronic liver allograft rejection usually is not seen before a -t. "' .... ' , __ . K~ :~K • v', 
2 months [IS5] after transplantation and most frequently... ... ·i--V --~_K • - . . ,. 1)-' .• ~ 
develops after: 1) an unresolved episode of acute re)'ec- .. ~KIKIKKKK;KK- - ... Du~_K _ ~DI : . 
• ,.. "'., ~-~ . K:~~ . ..,:!, . tion: 2) multiple episodes of acute rejection: or 3) indo- ...... 'W. ' ... ,t.._.- ., •..• 2It. 
I I . d f h ' f .. .." ~K -~ ~ ent y o'er a perm 0 mont s to years. with ew or no ~K _ ,. ~D~"D;t ..... .. . 
clinically apparent acute cellular rejection episodes [27]. ~DKD • :... ~_K -:~ DiirKK:~ ". ~:: ... 
Risk factors have alread.v been discussed. Often the onlv. .".. '4>' y~I .. :,;-.. ..... ~K .. :..... \.) --..... , 
reliable early indicator ofCR is persistent and preferential ~ ~"-D ~~i-D~ a ~ D~~ .. ~~ ."." 
ele\'ation of;'-glutamyl transpeptidase and alkaline phos- !DKIi-~K "."\. IK_~ .. \.:tr ',' .1f4 ~~/"~~;K 
loss [26.27.69.71.73.187-191]. If clinical symptoms are pre-#f,'j I~~KKKK ~ ....... ~ ll-/ • . "} phata,e [27. 186J. which is related to bile duct damageand "'.' , tto 
sent. they usually resemble those of acute rejection. until ~<1t ..... , .• \: ' '': (." :' ~ " ~ 
allograft dvsfunction becomes severe enough to cause ~ ..... -KK~ _ .. • ' K~I-I~I ~ .. "I 
jau;dice [26.27.69.71.73.187-191]. Biliary sludging or ap-·-... 1>' .. ~~ ...... -w -.A .,.- ... ~KK • ,..,. 
pearan:.:e of biliary strictures. hepatic infarcts. and finally b .;- '.,. .. .,., ... ~K 1t'-..' • .. ...: 
luss of hepatic synthetic function. which can manifest as 
coagulopathy. malnutrition. and hepatosplenomegaly 
[27]an: late findings presaging allograft failure. 
Chroni:: liver allograft rejection is histopathologically 
Jdined by two main features: severe damage and loss of 
small ( < nO.um) bile ducts and. as in ~Illl other solid organs. 
0.-\ [26.27.69.71.73.187-191]. Cases with either isolated 
bile Juct loss or foam cell arteriopathy alone may occur. 
but usually both features are found together [72. 73 J, 
L'nfortunately. arteries with pathognomonic changes are 
rarely present in needle biopsy specimens. and therefore 
what has been observed about OA in the liver has come 
from examination of failed allografts removed at the time 
uf re-transplantation. Therefore. in biopsy specimens. sig-
nificant weight is usually placed on damage and loss of 
small bile ducts. but ductopenia can be non-specific find-
ing that occasionally occurs as a result of non-rejection-re-
Iated complications [192]. 
.-\5 with CR in other organs. the inflammation is often 
inconspicuous. consisting of lymphocytes. plasma cells 
and macrophages [116. 126. 193J. Despite a paucity of 
portal intlammation. intra-epithelial lympho01es are 10-
cared adjacent to dege!1erating biliary epithelial cells [26. 
27.69.71.73.187-191J. which shO\v uneven spacing of indi-
\idual epithelial cells. eosinophilic transformation of the 
c:-1oplasm and ducts only partially lined by bile duct cells 
(fig, 3) [194]. The portal infiltrate is Tcell predominant in 
CR and contains both CD4 and CDS subsets [116.126. 
1l).3]. with the latter predominating in and around the 
c • 
~K 
Fig. 3. a) q~Is sectll~ shows some of t"e mOSt C~grgc:erfptlC changes 
asSOCiated With me earlier pnases "r chroniC lIVer allograi: relectlon, Note 
the "atrophIC" appearance of the ~diary ep'tnellum, arcow' There IS uneven 
spacing of the ep'tnel,a, cells, eOSinophiliC :ransiormat'on of the CytOpla5'" 
and focai pyknOSIS, b) Inters:lngly, even :~ough t~ese CUCt.l1 cells are "atro· 
phlc" appeanng. they CJr. snow In tnc;-eJsec ;:lroilfe"at:o'l rlte. as determined 
by Ki·67 stamlt1glarrowl, c) Evemc<.llly, the s"'ail :'IIe cuc:s are completely 
destroyed In c~ronrc live"" l.l!ogrJft re'ectlon Cy:oKeratlr; S:J.tnrng can De usee 
to help Identify the ducts, but It " Llsually not needec :268: Whether these 
few penpOr...l! cytoke-Jt!n-, 9 - cells In tnlS c:-',ronlcJliy ;e~ec:ed Ilverlar-
rows). represent progenitor cells CJoable of regeneratl."lg the <lucrs. IS worc"y 
of further study! see te x:! 
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biliary epithelium [193]. Increased (-interferon. IL-2. 
granzyme B transcripts [126] have also been detected. the 
last of which strongly suggests that a cytolytic effector 
pathvv'ay of injury is involved. The damaged ducts can also 
show "inappropriate" expression of the major ABO blood 
group antigens [195). the signific::mce of which is uncer-
tain. The diagnosis of CR at these "earlier" stages [192. 
194. 196-198] can be difficult. Review of previous biopsies 
and clinical correlation typically show a patient with docu-
mented acute rejection. that has progressed to chronic 
injury and prolonged liver dysfunction. which has not 
responded to appropriate anti-rejection therapy [27]. Tht! 
diagnosis of CR can also be supported by selective hepatic 
angiography that shows pruning of the intraht!patic arter-
ies with poor peripheral filling and segmental narrowing 
[26.191.199.200]. 
Interestingly. dt!spite the destruction of small ducts. a 
ductular reaction. or compensatory ductal proliferation in 
the marginal zone is not generally seen. unless the patient 
recovers. In such cases a "ductular reaction" has been 
described before clinical improvement [71,201.202]. 
\Vhether the recovery of ducts is related to proliferation 
of residual ductal epithelium. maturation ofliver progeni-
tor cells. or met:lplasia of periportal hepatocytes. is a 
intriguing question about liver grO\vth and development 
(129). 
The portal tract connective tissue assumes a "scarred" 
appearance by routine light microscopy. which is related 
to a destruction of tht! peribiliary plexus [80]. An increase 
of extrace llubr matrix proteins fibronectin. tenascin. un-
dulin. and collagen VI [134] have bt!en described in the 
perivenuiar regions and this is associated with an accumu-
lation of alpha-actin-positive cells and TGF-beta1-ex-
pressing macrophages in the areas [134]. 
Since the presence of foam cell arteriopathy can rarely 
be confirmed by a core needle biopsy. other "surrogate" 
features are often used to suggest the presence of OA. 
Features that suggest but do not prove the presence of 
foam cell arteriopathy includt! loss of arterioles and small 
( < 2U,um) portal tract arteries. centrilobular hepatocellu-
lar swelling. perivenular sckrosis. :md centrilobular hepa-
tocytt! dropout [26.27.69.71.73.187-191]. 
Lobular changes commonly seen in CR include cen-
trilobular hepatocanalicular chokstasis. intra-sinusoidal 
foam cell clusters. mild spotty acidophilic necrosis of he-
patocytes. centrilobular hepatO<.:yte atrophy and/or bal-
looning and perivenular sclerosis [26.27.69.71.73.187-191), 
The centrilobular degeneration and pt!rivenular sclerosis 
may be related to either ischemia or damage from re-
peated bouts of "central venulitis" during acute rejection. 
A.s with other orc:ans. the diagnosis of CR is easier to 
establish in an explanted fili/cd al/ograji. The presence of 
significant foam cell at\. should be seen in at least somt! 
ot the muscular arteries in tht.: hilum [26.27.69.71. 73. 1S7-
II} 1). ~1ajor hilar bile ducts may show sloughing of the 
epithelium. fot.:al nt.:crosis. intraluminal papillary hyper-
plasia of the epithelium. m ural fibrosis and acute and 
chronit.: intbmmation [203]. 
There an.: rwo fascinating aspects of chronic liver allograft 
rejection: its pott.:ntial n:versibility ['71.202). which has al-
readv bt.:en discussed: and an ap[1reciably lower incidence 
than otht.:r all'lgraits (Llble 1. [51]). Experimt.:ntal animal 
studieS have also shown that a liver allograft can also 
protect other organs from the samt! donor from CR [87]. 
Resistance of liver allografts to CR can best be ex-
plained by the immunological theories of so called "he-
patic tokrogenecity". They can be broadly separated into 
t\vo general categories. based on \\ihether emphasis is 
placed on the parenchymal or non-parenchymal portion 
of the liver. which in turn. results in: 1) deletion or 2) 
functional anergy in the responding T cell repertoire. 
Rekase of soluble donor ~[eC class I antigen from the 
allograft. supporting the importance of the parenchyma. 
does not seem to be a tenable hypothesis [204]. Murine 
liver allografts are routinely accepted bet\veen strains of 
mice that show no difference bet\ ... een the class I loci. but 
are mismatched for class II [205]. In addition. fully allo-
geneic liver allografts from class I or II MHC deficient 
mice. which do not shed soluble MHC antigens [205.206]. 
are also accepted. Moreover, otht!r organs also secrete 
soluble MHC antigens [207] but they are routinely re-
jected. and infusion of exogenous soluble MHC usually 
leads to only slight graft prolongation. 
One potential explanation for the importance of the 
parenchyma relies on the concept that allogeneic hepato-
cytes provide only one of t\vo signals needed for allogeneic 
lymphocyte activation [208]. Lack of important co-stimu-
lator,' molecules is thourzht to result in the induction of 
;.mergy in the responding lymphoc!te populations [208]. 
However. when transgenic mice that aberrantly express 
the allogeneic ~leC class I molecule H-2Kb (Kb) in the 
liver. using a metallothionein promoter [209]. are crossed 
\vith a strain that develops CDS + T cells specific for the 
Kb molecule. lymphocyte-mediated "autoimmune" liver 
damage can be induced under certain conditions. Inter-
estingly. most of the CDS.,.. cells responsive to Kb were 
eliminated by the intt!nse intrahepatic activation. but 
some ur the liver continued to show chronic low grade 
intlammation plY]. However. great care had to be taken 
to assure that alloantigen expression \Vas limited to the 
liver (2()9), Interpretation of these complicated experi-
ments is difficult. but it appears that the liver may be able 
to effect an activation-induced partial donal deletion or 
allogeneic lymphocytes [209]. as originally proposec by 
Kamada [210J. This may represent a special circumstance. 
because alloantigen expression on other non-hematolym-
phoid cells such as pancreatic islets. does not lead to 
anergy [211]. but to immunological "ignorance" [212). 
which is an important ditlerence. Induction of true anergy 
may in fact. n:quire presentation of antigen by profes-
sional antigen presenting cells. 
It has been our contention that so called "hepatic 
tolerogenecity" is in large part. a result of hematolym-
phoid microchimerism [48.213.21.+] sustained by donor 
hematopoietic stem containt!d within tht! liver [215-217J . 
The immunologic m..:chanisms involved in graft accep-
tance is initially. a non-dt!letional. active process that 
appears to require the pr..:sence of do~or APC [87.218). 
In microchimeric recipients. the donor cells cause low 
grade proliferation and 3ctivation of the recipient immune:.: 
syst..:m [51.87.218-220J . inciuJing acti\'ation of B cells 
[219.221) ;.md altc:.:rations in IL-4 production [222J. This in 
turn. leads to hypores[1nnsivene:.:ss to donor antigens and 
graft at.:c.:ptance. 
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A recent series of investigations by Bishop et al [223-
226] add credence to the viewpoint that hematolymphoid 
cell-induced activation of the recipient is important in 
liver graft tokr;:mce. Comparing spontaneously accepting 
and rejecting rat strain combinations. they have shown 
th:.lt acceptance of the original liver :.lliograft and sub-
seque!nt gr;].fts from the! s;].me donor. resides with a popu-
lation of radio-sensitive! he!matolymphoid cells within the! 
live!r [226]. Destruction of the! hematolymphoid cells by 
irr:.ldiation or blockagt: of the response by a short course 
of me!thylprednisolone reduces sUI\:ival of subsequent do-
nor strain skin gr:.lfts [226 J. 
Hearr 
Obliterative arteriopathy is the major manifestation ofCR 
in c:udiac allografts. unfortunately. cardiac allografts are 
also susceptibie to AS that is e~demic in tht! general 
population. This results in the frequent transmission of 
coronary artery disease from tht: donor to the recipient 
[56-58]. Thus. AS and OA both contribute to the arterial 
disease seen in allografts before and after cardiac trans-
plantation [58.227-2·30]. 
Cardiac dysfunction associated with CR is largely be-
cause of ischemic damage to the heart. However. the 
classic;].l symptoms of m;'ocardial ische!mia like angina 
pectoris. are thought not to be! reliabk indicators in the 
he!;].rt transplant re!cipient. since the! allograft is dener-
\;].ted [3]. ~ey"erthde!ssK in a series of 25 myocardial in-
farcts in he;].rt transplant recipients (231) . symptoms in-
dudt:d chest pain (n=2). arm pain (n=3). weakness 
(n = lIi). dyspnea (n = 11) ;].nd palpitations (n = 8). Three 
episodes were clinicallY silent. detected onlv as ne\v dec-
troc:.lrdiographic changes during routine follow-up and 
t\vo patients had old Q waves. Of the! 8 patients hospital-
ized with symptoms. only i had typical Q-wave changes on 
e!ectroc:lrdiography: 5 had nonspecific ST-segment chan-
ges and 2 had no documented changes. Se!rial creatine! 
phosphokinaSe! levels \ve!re obtained in 13 patients. and 
V:ll UeS were e!e!vated in 8. Otha manifestations of CR and 
myoc:lrdi:ll ische!mia indude c:lrdiac enlarge!me!nt \vith 
\'e!ntricular dilatation: loss of papillary musck function 
:lnd mitral re!gurgitation: ventricular wall dysfunction (3) . 
constrictive pt:ricarditis [232] and the: developmt:nt of 
con~estive heart failure and/or cardio!!e:nic shock. which 
can -be! misdiagnosed as infection [231 r 
One! might t:xpect that pre-e!xisting coronary artery AS 
would accelerate! the! dt:vt:lopment of 0.-\. Indet:d. thl.! USI.! 
or olde!r donors has be!en :lssociated with a higher inci-
dence of vascular abnorm:llitit:s e!arly :lfte!r transplanta-
(lon [57.229.2331. Hovie!ve!r. pre-existing donor artery dis-
I.!:.lSe! dOe!s not ne!cessarily impart :In incre!ased risk for the 
development of OA [5i.23.+J, which de!ve!loped at dit"fa-
e!nt sitl.!s in the! wssels. This su£!£ests that at least somt: of 
the pathoge!nic ml!chanisms r~;ponsibk for OA arl! dif-
taent from thosl! involve!d in AS. Cle!arlv. more detailed 
investig:ltion into the association b\:!t\veen OA and AS is 
nee!dl.!d. 
Soml.! of the c;].rdiac pathology can be! ddectd by 
\!chocardiography or saial r:ldionuckotide angiography 
bdort: classic symptoms and signs of he! art failure! ariSe! [3], 
Althou~h thl.!sl.! ml.!thods of obsl.!rvation arl.! less sensitivl.! 
than hi~top:Klthological e!xamination of the! e!nlire! allograft 
[235], they are more reliabll! than evaluation of endomvo-
cardial biopsil!s. which can rarely dl!tect OA (see belo~FK 
Gao I!t a!. [236] originally c1assifil!d the angiographic 
abnormalities into three categories: type A. discretl! or 
tubular stt:noses: typl! B. diffuse concentric narrmvim!.: 
:lnd tYpl! C. narrowed irregular vessels with occ1ude-d 
branche!s. Cs\:! of this classification or something similar. 
has proved to be a usdul approach when applied to allo-
graft coronary artl!ry pathology. Type A Il!sions of the! 
primary epicardial coronary vl!ssl!ls. with less frequl!nt 
se!condarv branch involv\:!me!nt are most commonlv t:n-
counterl!d in non-allograft he!arts. Not unl!xpectedlY. the! 
sam\:! type of ksions are detected in the allograft popub-
tion shortly after transplantation. consistent with trans-
mission of donor disl!asl!. Howl!ver. type A Il!sions involv-
ing secondary and tertiary branchl!s dl!velop more fre-
quently in allografts than in native hearts. In addition. type! 
Band C lesions (diffuse narrowing, tapering and oblitera-
tion). are much more common in allograft coronary arter-
ies than in nativl! hearts and involve primary, secondary 
and tertiary branches [236] . Total vl!ssei occlusion is 
found predominantly in thl! proximal or middle vessel 
segme!nts of atherosclerotic disease. whereas distal in-
volveml!nt can be seen in up to one half of patients with 
OA Failure to develop collateral Vl!ssels is also more 
common in allograft recipients with OA.. Based on theSe! 
obse!rvations. Gao et al. [236 J concluded that coron:l!!' 
artery diSeaSe! in transplant patients represents a mixture 
of typical AS and unique transplant-related progressive 
distal oblitl!rative disease that occurs without collateral 
vessl!l development [236J. 
S\:!ver:ll investig:ltors have dr:lwn thl! same conclusion 
using the more recently developed intravascular ultr:l-
sound [58.227-230). This te!chnique offers some advan-
tages over angiography in tt:rms of sensitivity [233.237. 
238] ;,lOd the ability to more precisl!ly characterize changes 
in coronary vessel shape and wall thickness [239]. which 
enable!s one to follmv the! changes over timl!. In general. 
lesions frequl!ntly detectt:d t:arly after transplantation fe!-
t1e!ct donor AS in the genaal population: segmental :lOd 
e!ccentric intimal thickening and lumenal narrowing, pri-
marily involving thl! epicardial coron:lry :lrteries and the!lr 
primary branches. Over time. more distal. diffuse non-
calcific and concentric intimal hyperplasia develops [58. 
22S.230.238.240). which likdy represents OA.. 
Serial intracoronary acetylcholine infusions and quan-
titatiVe! angiography havl! conc1udl!d that endothelial cell 
dysfunctilln is fn.:quently ObSe!I\'e!d in allograft coronary 
arte!rie!s and it often occurs early aftl!r transplantation 
[2.+ 1.2421. A closl! associarion betwee!n endothelial dys-
function and intima abnormalities can be documente!d in 
som,l.! [2.+ 11 but not all studie!s. presumably because of the! 
e!pisodic n:lture! of the! immune injury [227J. Other abnor-
malities include an impaired rl!sponsivene!ss of I!picardial 
:lrterie!s to incrl!;lsed now [242]. 
Except for rar..: cases [2'+3]. e!ndomyoc:udial biopsies do 
not show change!s that can be reliably used to makl! tht: 
diagnosis of CR [tS4.65.2.+.+-2.+SJ. Intimal thickening dOe!s 
not usually atI..:ct the! small pe!ne!tr::lting intra-cardi::lc art\!-
rioks prese!nt in endomyocardial biopsies [79J. and colla-
gl.!n dl.!nsity in biopsy spe!cime!ns does not appear to pr\!-
Jict:lbly incrcasl.! \\iith tim\;! in patients who de!vc!lop CR 
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Fig 4 . .:1) :K:~~ .. ')sc e"D:~:: 'es ::-:$ Invcivlng ~he ep1cardl<l.l coronary3rterres are Erequentlyecc:e~K: .. ,: 1"_ ~ :--,: '::S:',:'-:: :'-:;:3. JS S :';':''''' ,n :~fp lesion from 
"; :gI~::CD:;I :'S .... 1·: b) -c: ... ..::- K~ .. 00.\ ieslon CJn Jiso have an eccentric distnbutlon J.S shown her~ "H::::': :-''': : .:' :' K::;K"::D~:K:II"D; :"C ':.;-::-,;: f"t:f'f1.Ji macrophages 
1--: ···S C:~P DDDD·DDK:c:~ :~K:: seen In Figure I from a liver allogr:lft. c) In contrast to atherosc:eD~pDA ;:.,. :',,,,, "·c"·,, :~" :: st~1 :-:-:'1es 'Ji tne epicardial 
::c:":r. , . ..,.,. e' w~ d) "KI~" :~cse snOJIler Intra.myocardlal branches (arrows). There IS also ~e;:c~C:M":D , .... ,"':-C::C :-D:CC·I-M::KDg:~re oi:he heart'" 
C=\ e ;".; f -= :;III~I"!IKK~ : ..... 0: I .... ~K :D~g[IC cr . .1nnels (bLJck: histochemical stain for 5' nudeotrdJ.SeJ trgKt~··sKr .s C; ': : ~ID >_.: FDDD:D~ :.-:.,: ...• :~ ,1rte'" -:: r -1 -,orrnal heart(e) . 
•••. ~~D --.:, -1'--;- :f :;:.111"·':5 ';ce'"' ~ J CJ.rCI.1C lilogra.ft With CR(f). 
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[132]. There is however. some evidence that nodular sub-
endocardial lymphm:ytic aggregates or Quilty lesions 
[244] may be associated with OA. 
Quilty lesions are present in 4-2511: of human endo-
myocardial allograft biopsies and are detected on at least 
one occasion in RU-TU~ of patients [246.247.249. 250]. 
Although they are not the equivalent of therapy-requiring 
acute rejection. some clinical studies show an association 
\ ... ith acute rejection in the underlying myocardium [247. 
251-254] or with OA [248] . Patients in the Stanford series 
\vith Quilt;., lesions who underwent transplantation in the 
early 1980's had the highest incidence of graft vascu-
lopathy [123] . but more recently the incidence of OA has 
significantly decreased in these patients [123]. This per-
plexing observation might be explained by the fact that 
these patients had the most potential for improvement. 
particularly with the addition of new immunosuppressive 
regimens. For example. Tacrolimus has significantly less-
ened the incidence of Quilty lesions in our heart transplant 
recipients [255] and significantly increased the half-life of 
kidney allografts [256] . presumably by lessening CR. 
Even though a causal association of Quilty lesions with 
OA is unlikely. these observations suggest that Quilty 
lesions might not be innocuous histopathological curiosi-
ties. Their presence in animal models with persistent al-
loactivation and developing OA [87] suggest that they 
serve as a Ri~mal of indolent om!Qin\! immunoloe:ical dam-
age. which has the potential to -conrribute to the develop-
ment of OA. Kemnitz et a1. [253] offered an explanation 
for the possible association be[\veen QUilty lesions and 
OA by speculating that they may represent form ofvascu-
lar rejection. since the heart develops embryologically 
from primitive vessels. 
Consistent with an immune etiology [1.59.65.83.235. 
245.257]. it has been our experience in humans, that pure 
OA. frequently involves both smaller intramyocardial ar-
teries anu epicardial coronaries and infrequently shows 
eccentricallv situated and grummous atheromas and cal-
cifications (fig. 4). In addition. the fibrosis in CR often 
extends along the connective tissue septal containing the 
affected arteries. This is in contrast to AS. that tends to 
show proximal epicardial coronary involvement by eccen-
tric lesions with grummous atheromata and sparing of 
intramyocardial branches. OA can also clearly be shown 
to develop directly from inflammatory and/or necrotizing 
arteritis is some cases [77.83.235]. much like experimental 
animal models [85.87.95]. However. as already pointed 
out. even though OA involves both proximal and more 
distal portion of the arteries. OA is often not as diffuse or 
concentric as one might expect from a review of the litera-
[1 -9S-U~KI~-KI·D-"-Tz I . OA' ture .).) . .)._.))._'t)._) . n our experience. IS 
often patchy in distribution (preferring branch points as 
epicardial vessels penetrate the myocardium). shows a 
significant adventitial components. can develop eccentri-
cally. and frequently does not extend to the smallest arter-
ies and artt:rioles present in endomyocardial biopsies [63. 
79J. This is consistent with experimental animal models 
whert: the OA lesions are dc:finitdv a result of immune 
injury. but notoriously hderogeneoi.Is in distribution and 
severity [1:!5.87.95]. In fact. the distrihution is so heteroge-
nt!ous that elaborate sCl)ring systems arc rt!quired to quan-
tify tht! findings [1-)5.87.95]. 
However. in an individual lesion. the relative contribu-
tion of OA or AS may be difficult to determine. This is not 
surprising since atheromas are frequently inflamed with 
donor hematolymphoid cells and therefore would be more 
immunogenic than other constituents of the alloe:raft. 
Conversely. McManus et al. [105.107.121] have sho",; the 
tendency for OA lesions to imbibe lipids. Thus, some 
histopathological studies of failed allografts and autopsy 
specimens have encountered some of the same difficulties 
as the imaging studies: Atherosclerosis and OA both con-
tribute to the coronary artery disease seen in allografts. 
This might explain some of the more recent apparent 
inconsistencies in the distribution of OA noted by investi-
gators using intravascular ultrasound [258]. 
Small imestine 
Transplantation of the immunologically difficult small 
bowel. has only recently been clinically achieved to any 
significant extent [259-261]. This was largely because of 
ineffective control of acute rejection. which was made 
routinely possible by the use of FK506 (Tacrolimus) im-
munosuppression [262]. Thus. until recently, when the 
entire spectrum of human pathology was delineated [25]. 
most of the CR chane:es small bowd alloe:rafts have relied 
on experimental animal models [139.140.263-265]. 
In experimental animals. CR of the small intestines 
often evolves from suboptimally controlled acute rejec-
tion [140]. It is characterized by OA. hyperplasia of the 
muscularis propria [266]. apoptotic death of epithelial 
cells in the crypts of Lieberkuhn. villous blunting. focal 
fibrosis of the lamina propria. and destruction of donor 
mesenteric lymph nodes and the mucosal-associated lym-
phoid tissue(Peyer's Patches) [140]. The last complication 
results in focal mucosal ulcers [139.263-267]. Although 
experience in humans is limited. detailed evaluation of the 
few chronically rejected human allografts [25] have shown 
the same set of histopathological changes as seen in the 
experimental animals (fig. 5). 
As with other allografts. the biopsy diagnosis of CR in 
humans is difficult. The vessels affected by OA primarily 
the distal branches of the mesenteric arteries and the 
larger arteries of the serosa and muscularis propria, are 
not routinely sampled. Therefore. one is forced to rely on 
"surrogate" findings. These include focal. non-healinl! 
ulcers:-a distinctive-combination of ree:eneration and evi: 
dent crypt epithelial apoptosis: and a disordered mucosal 
and villous architecture with fibrosis [25]. Typical clinical 
findings that support the diagnosis of CR include, persist-
ent diarrhea with non-ht:aling ulcers. repeated bouts of 
suboptimally controlled acute rejection: and either non-
compliance with immunosuppressive medications or de-
liberate withdrawal of immunosuppression because of 
life-threatening infections [25]. Endoscopic and radio-
graphic studies used to support the diagnosis of CR in-
clude focal loss of mucosal folds. focal ulcers and mural 
thickening, and pruning of the mesenteric arterial arcades. 
rt!sp~ctivelyK 
Incompleteness of the direct injury model 
In addition to immunological arterial injury. a number of 
clinical and t!xperimt:ntul observations suggest that other 
factors contribute to the de\'clopmt!nt of OA [6.16.51.63. 
a 
c 
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Fig, S, ,,) '::= :: - -':- ,:",,1 ~lDK·D~f allogr::: ;nowS :ocal. non-healing ulcer~larDowDI as ;nown here, and thlC!<enlng lno 'ibrom:;: :~e submucosalsm), b) 
:. - s-~D ~Dr ': c,: :; - :r :-c lu~r-ccosa :"e"e}IS abu~cant foam cell deposition, w,-,dar :0 :nat leen In the ar.:erlal Ir:'[T1a of oloe:: . esse's with OA. c) Like 
::--=": -: ;"'-;':: :-~ ·,'-::'-'es J.;':-:c:ec by C.":", Jre :lor c:mmoniy sampled in :'Iopsles. Tr,!s ~ec!:lon snows J mesenteriC .lrtery wIer, C;!. .... e:lr l mesenteric lymph 
-~-;!I .... :-:: : :::: 02':'0:' )r-:; ;it:rO$,SiJ,P'"OWI. d) A higher magnificatIon shows ~1id :yr10ncCl'::c intimal :ntb.mmJ.::on. In':Iri:JJ ;::aIT. cell deposltlon and 
~-: ::-,,-,':= - D:-:":-:~~DI ".c:e },SO ere ",,,rked :nedlal vacuolization, .vhIC,"'\ :5 cue:o foa,,-, cednt1ltratlon ~erkeen ,T\VOC'ICes :,-:: :ntercellular edenra. 
-11IDD::;E:~dDic: ,::" Tile: Dire:d Injury \-lodel also dOeS not 
~gdr;K;" [l~c: ffl~ rn llnul, F~ic:al m.:c:hJ.nisms responsible for 
r'.:>i'oCc:IH II!:":;~Idt inJurY, This is probably related to an 
ll~EI y;~~lic::KK: ur~c!C:!DDo[Ifr1din~ elt thl' mec:hanisms of graft 
dl''':':!'[d::C, ,In,,: ,I :i:ltlll,t! rr.:-\)cc:upation with the mokt:u-
I", ;~:i_D::ID:"D:~" ,'r [i:.: (llIHr(11 \It sm()oth musde cell pro-
D::I:~II::"f:D:;": :;:D~fF~e:!liDDoiDo [n (lurtlpinilln. one met:hani-
c,t! ~I;c:"r [:1 .. , D:~Elllfg r":C":I\L' mllre: J.tcc:ntion is the dt.:-
D:~DIIID::"fi ,,: yDr;_!rhl~"FC:l~f[K:g hmphoid tissues and lym-
['i:,::c ":::Ili~;:Do<DI ,,\hl\,,':l ~tfyyllC: L':ln elUSe J.rterial pJ.thology, 
Fl;~: I:,::::. J,>::',:":::I \n,)t tile: y~f~EFy~surumK could indirectly 
I:::,::'..: :::.: ',\,::: ,)[ L,,:;c:r \e:s'o.:b and trigger a repair re-
'i" '>, l,,==,,:-Jk'o'o, :lIi\ hYr\l[h.:sis or' 0.-\ pathogene-
,!, ....... .: :.' A,I '11, tn, ,J,It.: [h.: inade:4uatdy explained 
:i:~_:D::::DlI:K:d I:~ Td,ic'::, In :IJJitilln. it mJ.Y be helpful to 
'. :e",\ ( R,'o :':'0 ;::Ti.:t.: [(,kr:ln.:.:, hy c:omparing recipients 
.,\ i:: CR :" ;y"D:1D:::c:lll~ -1,i..:ntic:,tI':(lntrub who are tolerant 
[" : .:c' ~DIfID _ i :-.< _'il'; ,)1[< 1 i'ol ':,:r:dr, c:\ )ntrois, as is c:ommonl;.-
,,:\1",,: I:' I:::~y iDy;DI-Dril!h_Dl1t~t! Dy:"DtiDln~K 
CR viewed as a "Incomplete Tolerance" 
Implantation of J.ny solid organ allogr:Ht results in a char-
J.c:tt:ristic: c:\'de of hei!!hknc:d immune: Jc:ti\':.ltion. brou2:ht 
ahout th.: initIal eng:igt.:menr tJf the Jl)nUr J.nd recipi~nt 
lymphoiJ systems [-1-:).21-1-.21,':.211.'1]. fol!uwed by evolution 
towarJ a more stJ.bk relationship \\he:'1 immunosuppres-
~ion -:an he collsidcrJ.bly l()wereJ ur e:\c:'1 withdrawn [269. 
2'70]. In th.: past. this prototypic: ,c:cs of events was 
~ttributK:g to the presl!nc:.: of passen;er leUkocytes or 
Jonnr h.:matolymphoiJ c:dls [2'71-2'73]. It was thought 
that they were essl!ntiallv Jekrcrious r,) allof.!r:1ft survival. 
anJ ser~Deg only [0 din;c:tly sensitize :he r~dpient [271-
2'731. \Vhen th.: Jnnor c:dls were: Jestn'yeJ or Jied out. the 
Jonnr re:c:ipi.:nt immunological interfac:;: b.:c:ame less con-
tentious, HllWe\'er. in some dinic:~11 [.1";.2--1--277] and ex-
rc:rimD:f1[~d sy,t,;ms [S7.27S,2-:-LJI, the: e,ad opposite was 
~I;tu~dly fllunJ: ullnnr h.:marolymphtllJ .:ells persisted in 
DilE:cI;s~ful long term J.lIllgr:lf! r.:c:irit::1t,;. but were de-
stroyed ill r.:ciriL'l1lS with CR. This rilenniT1enon cJ.lled 
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~f Table 2. Observations not adequately explained by the Direct Injury Hypothesis(see text) 
Observation 
Markers of severe acute relectlon(alloanobodies or IOflammatory arterI-
tis). not always detected before development of OA. 
Coronary arteries of composite heart·lung allogr.lft reCipients are less 
frequently and less severely affected than coronary arteries in isolated 
heart ailogr:lits (table I). 
Pulmonary artenes are less severely affected than coronary arteries in 
heart-lung tr:lnsplam recipients [64J 
Inadequate explanation for progression of OA in absence of immu-
nologIC Insult [17.89]. 
OA is not a feature of graft versus host disease 
"microchimerism" uncovered a paradox [218J. resolution 
of which required a paradigm shift in transplantation 
immunobiology [21 .. L218J. The neVi. TV'io-Way paradigm 
line of reasoning hypothesized that donor hematolym-
phoid cells are necessary. but alone. not sufficient for 
tolerance induction and thus. freedom from CR [48.87. 
213.214.218.278.279]. 
\Vhile attempting to study microchimerism. we in ad-
\'ertently created a clinically relevant experimental animal 
modeluf CR [87.280J. In this model. gendically identical 
recipients were m~lEje CR-resistant or CR-prone by pre-
treatment with a donor liver alloe:raft or bone marrO\\i 
infusion. respectively [87]. ::md then challenged with a 
cardiac allograft without immunosuppression. Both 
groups unde!"".vent a transient Clcute rejection within days 
after p!J.cement of the cardiac grafts. but \vere operation-
ally tolerant. The cardiac grafts were accepted and remain 
functional tor more than 100 days. HO\liever. those pre-
treated \vith a bone marrow infusion were incompletely 
tolerant. because eventually they devdoped CR and OA. 
whereas thuse pretreated with a li\'erwere resistant to CR. 
.-\ more in-depth analysis showed that the acute rejec-
tion crisis in the two groups could be separated on the basis 
of macrophage migr:ltion. cytokine production and altera-
tions in \-IHC ::mtigen expression. Acute rejection in the 
CR-prone Clnimals \vas characterized by an int1ux and 
accumulation of recipient macrophages: persistent and 
strong upregubtion of class II ~feC antigens on the 
vascular endothelia: loss of intra- and extra-graft and 
donor hematolymphoid cells [87] and a <..ytokine mR.',L-\ 
response enriched in i'-interferon. IL-12 and macrophage 
acti\"ating chemokines(Murase. manuscript in preparation). 
In contrast. the strong upregubtion of ;.--interferon and 
lL-12 \vas not seen during acute rejcction in the CR-resis-
tan t animals .. even thoue:h there was evidence of e:raft 
intlammation hv histolo! ... ~· and immune activation b~D cv-
tokine chemol.Jne mR:-.i.:\ analysis [S7]. In addition. e~d~F­
thelial class II \lHC expression in the CR-resistant recipi-
ents was weak and transient and donor hematolymphoid 
cells refsisted in the graft and recipient lymphoid tissues. 
Possible explanation(s) 
- Severe acute relectlon and Inflammatory arteritis not required 
- MechanICal fac:ors involved 
- Antigen quaJiry or quamlry IS of importance 
- MechanICal fac:ors Involved 
- Antigenic or mlCroenvironmental differences Important 
- Initial injury tnggers self-perpetuating repair response. perhaps driven 
by normal physiology 
- Mechanical factors Involved in organ removal and implantation important 
Like other CR models .. this one shows a clear link 
bet\veen CR and macrophage infiltration. which in turn. 
is likely related to the production of;l-interferon and other 
macrophage activating cytokines [97.177.180.267.231]. 
There is also evidence of persistent endothelial and 
smooth muscle cell activation. such as expression of \-IHC 
class II [87] antigens and adhesion molecules [17.85.97. 
11 .. 1..1 15.118.155.156.163 .. 176.2 .. 1.1.282]. Cnlike other mod-
els however. it shows that arterial remodeling starts to 
occurs during acute rejection before any intimal int1am-
mation is seen. In addition .. this model enables the inves-
tigator to compare and contrast completely tolerant re-
cipil:!nts to those who are incompletely tolerant and de-
velop CR. \-lajor differences between these two groups 
are the persistcnc:.! of donor hematolymphoid cells in the 
former. and heightened recipient macrophage int1ux in 
the latter [Ki]. Thus. our model more closely resembles 
the clinical cases that indokntly develop CR. 
The slower e\'olution of CR in some cases may be 
related to the mode of alloantigen presentation. As C'rigi-
nally predicted by Batchelor [283] .. acute rejection is likely 
dominated by direct presentation of aIIoantigen by donor 
APCs. whereas CR may be primarily mediated via indirl:!ct 
alloantigen presentation by recipient APCs .. consistent with the 
prominence of recipient APCs within the graft. Conversely. 
a bold and controversial hypothesis is that freedom from 
CR reqllires thl:! persistence of donor hematolymphoid 
cells [~hKUTzK The idea is that to achieve tolerance. the 
dOll or immune Y\'stem is required. since onc of its normal 
physiological functions is to establish immunological boun-
daries. or the "self' [4~KO1UzK Hopefully. the freedom from 
CR that is seen \vith au~mentation of chimerism usin~ 
h:.lrsh conditioning regimens in expl:!riml:!ntal animals 
[OU~KOURzK \vill be realized in unconditioned human recipi-
ents as a lower incidence of CR [38.286.287]. Whether this 
linl:! of reasoning is com.:ct or not. only time will tell. 
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